Phibro Animal Health Operating Margin 2012-2025 | PAHC
Current and historical operating margin for Phibro Animal Health (PAHC) over the last 10 years. The current operating profit margin for Phibro Animal Health as of March 31, 2025 is 6.58%.
| Phibro Animal Health Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $1.19B | $0.10B | 8.07% |
| 2024-12-31 | $1.11B | $0.08B | 7.42% |
| 2024-09-30 | $1.05B | $0.07B | 6.88% |
| 2024-06-30 | $1.02B | $0.05B | 5.21% |
| 2024-03-31 | $1.00B | $0.06B | 5.91% |
| 2023-12-31 | $0.98B | $0.06B | 5.91% |
| 2023-09-30 | $0.98B | $0.06B | 5.94% |
| 2023-06-30 | $0.98B | $0.07B | 7.46% |
| 2023-03-31 | $0.98B | $0.07B | 7.35% |
| 2022-12-31 | $0.97B | $0.07B | 7.40% |
| 2022-09-30 | $0.96B | $0.08B | 8.12% |
| 2022-06-30 | $0.94B | $0.08B | 8.38% |
| 2022-03-31 | $0.91B | $0.08B | 8.26% |
| 2021-12-31 | $0.88B | $0.08B | 8.64% |
| 2021-09-30 | $0.85B | $0.07B | 8.68% |
| 2021-06-30 | $0.83B | $0.08B | 9.00% |
| 2021-03-31 | $0.80B | $0.07B | 9.26% |
| 2020-12-31 | $0.80B | $0.08B | 9.40% |
| 2020-09-30 | $0.81B | $0.08B | 9.31% |
| 2020-06-30 | $0.80B | $0.07B | 8.61% |
| 2020-03-31 | $0.82B | $0.06B | 7.69% |
| 2019-12-31 | $0.81B | $0.07B | 7.99% |
| 2019-09-30 | $0.82B | $0.07B | 8.68% |
| 2019-06-30 | $0.83B | $0.08B | 10.14% |
| 2019-03-31 | $0.84B | $0.10B | 11.72% |
| 2018-12-31 | $0.84B | $0.10B | 12.04% |
| 2018-09-30 | $0.83B | $0.10B | 11.97% |
| 2018-06-30 | $0.82B | $0.10B | 11.95% |
| 2018-03-31 | $0.80B | $0.10B | 11.96% |
| 2017-12-31 | $0.78B | $0.10B | 12.76% |
| 2017-09-30 | $0.77B | $0.10B | 12.86% |
| 2017-06-30 | $0.77B | $0.10B | 12.94% |
| 2017-03-31 | $0.76B | $0.10B | 12.52% |
| 2016-12-31 | $0.75B | $0.09B | 11.44% |
| 2016-09-30 | $0.75B | $0.09B | 11.44% |
| 2016-06-30 | $0.75B | $0.09B | 11.45% |
| 2016-03-31 | $0.75B | $0.09B | 11.65% |
| 2015-12-31 | $0.75B | $0.09B | 11.72% |
| 2015-09-30 | $0.75B | $0.09B | 11.36% |
| 2015-06-30 | $0.75B | $0.09B | 11.76% |
| 2015-03-31 | $0.75B | $0.08B | 10.71% |
| 2014-12-31 | $0.73B | $0.08B | 10.23% |
| 2014-09-30 | $0.72B | $0.07B | 10.04% |
| 2014-06-30 | $0.69B | $0.06B | 9.10% |
| 2013-12-31 | $0.50B | $0.05B | 9.44% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.135B | $1.018B |
| Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. The company provides a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. In addition to animal health and mineral nutrition products, Phibro manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. Currently, Phibro focuses on regions where the majority of livestock production is consolidated in large commercial farms such as the U.S., Brazil, China, Russia, Mexico, Australia, Turkey, Israel, Canada and Europe. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $222.716B | 26.12 |
| Boston Scientific (BSX) | United States | $157.517B | 37.62 |
| Stryker (SYK) | United States | $152.893B | 31.97 |
| EssilorLuxottica (ESLOY) | France | $140.240B | 0.00 |
| Medtronic (MDT) | Ireland | $118.558B | 16.81 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.586B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.070B | 25.15 |
| ResMed (RMD) | United States | $40.718B | 30.58 |
| GE HealthCare Technologies (GEHC) | United States | $35.587B | 16.90 |
| Agilent Technologies (A) | United States | $34.042B | 22.19 |
| Koninklijke Philips (PHG) | Netherlands | $26.981B | 17.85 |
| Terumo (TRUMY) | Japan | $25.673B | 33.35 |
| Insulet (PODD) | United States | $20.514B | 80.52 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.786B | 12.06 |
| Baxter (BAX) | United States | $14.800B | 11.05 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.840B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.874B | 23.92 |
| Lantheus Holdings (LNTH) | United States | $4.995B | 12.60 |
| Perrigo (PRGO) | Ireland | $3.859B | 9.78 |
| Prestige Consumer Healthcare (PBH) | United States | $3.689B | 16.48 |
| Haemonetics (HAE) | United States | $3.629B | 16.53 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.441B | 28.59 |
| ICU Medical (ICUI) | United States | $3.119B | 23.00 |
| LeMaitre Vascular (LMAT) | United States | $1.863B | 41.64 |
| QuidelOrtho (QDEL) | United States | $1.720B | 11.83 |
| AtriCure (ATRC) | United States | $1.571B | 0.00 |
| Acuren (TIC) | United States | $1.369B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.272B | 28.62 |
| AdaptHealth (AHCO) | United States | $1.259B | 12.78 |
| BioLife Solutions (BLFS) | United States | $1.057B | 0.00 |
| Neogen (NEOG) | United States | $1.048B | 16.66 |
| Curaleaf Holdings (CURLF) | Canada | $0.933B | 0.00 |
| InMode (INMD) | Israel | $0.905B | 9.11 |
| Kestra Medical Technologies (KMTS) | United States | $0.847B | 0.00 |
| Valneva SE (VALN) | France | $0.660B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.632B | 0.00 |
| Evolus (EOLS) | United States | $0.596B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.581B | 0.00 |
| Owens & Minor (OMI) | United States | $0.576B | 4.78 |
| Surmodics (SRDX) | United States | $0.535B | 0.00 |
| CeriBell (CBLL) | United States | $0.533B | 0.00 |
| ZimVie (ZIMV) | United States | $0.524B | 23.81 |
| SNDL (SNDL) | Canada | $0.384B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.322B | 11.83 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.308B | 0.00 |
| Quanterix (QTRX) | United States | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.298B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.295B | 0.00 |
| Cerus (CERS) | United States | $0.254B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 74.00 |
| Biote (BTMD) | United States | $0.249B | 7.00 |
| Viemed Healthcare (VMD) | United States | $0.247B | 20.87 |
| Omeros (OMER) | United States | $0.245B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.245B | 0.00 |
| Brainsway (BWAY) | Israel | $0.224B | 59.15 |
| Sanara MedTech (SMTI) | United States | $0.222B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.217B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.209B | 0.00 |
| Organigram Global (OGI) | Canada | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.09 |
| Exagen (XGN) | United States | $0.180B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.177B | 0.00 |
| High Tide (HITI) | Canada | $0.175B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.18 |
| Jushi Holdings (JUSHF) | United States | $0.107B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.74 |
| Quipt Home Medical (QIPT) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Safety Shot (SHOT) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| Apyx Medical (APYX) | United States | $0.074B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.064B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.92 |
| Nephros (NEPH) | United States | $0.037B | 49.57 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |